XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
MarketScreener,
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a…
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a…
GlobeNewswire 2022-03-23 Compositions and Methods for Enhancing Anti-Viral Therapies CALGARY, Alberta, March 23, 2022 (GLOBE…
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV…
Compositions and Methods for Enhancing Anti-Viral Therapies This patent is based on retrospective clinical data from XORTX…
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV…
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV…
Compositions and Methods for Enhancing Anti-Viral Therapies CALGARY, Alberta, March 23, 2022 XORTX Therapeutics Inc.
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV…
CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV…
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
Compositions and Methods for Enhancing Anti-viral Therapies CALGARY, AB / ACCESSWIRE / March 8, 2021/ XORTX Therapeutics Inc.("XO…
Compositions and Methods for Enhancing Anti-viral Therapies CALGARY, AB / ACCESSWIRE / March 8, 2021 XORTX Therapeutics Inc.("…
Compositions and Methods for Enhancing Anti-viral Therapies CALGARY, AB / ACCESSWIRE / March 8, 2021 / XORTX Therapeutics Inc.
**● Compositions and Methods for Enhancing Anti-viral Therapies ●** CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- (" XORTX …
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX…
SARS-CoV-2 befällt vornehmlich die Atemwege und die Lunge. Aber die Infektion kann auch andere Organe angreifen.
Covid-19, die vom Coronavirus SARS-CoV-2 verursachte Lungenkrankheit, verläuft meistens mild – die Weltgesundheitsorganisation (W…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
| Spoke Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment Baxter…
Oxiris offers a new tool in the COVID-19 fight while supplementing our overall supply of filters for blood purification…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA…
DEERFIELD, Ill.--(Business Wire)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA…
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous…
DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International, Inc. (NYSE:BAX), a global leader in acute care, announced it has…
Share on Pinterest Doctors in New York City say the rate of kidney injury among COVID-19 patients is putting a strain on…
When dialysis first became a viable treatment option in the 1960s, it was a tremendous leap forward for patients suffering from…
The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who…
NEW DELHI: Kidney patients are more vulnerable to COVID-19 infections and management of patients on dialysis must be according…
Source: Government of India The COVID-19 pandemic is throwing up unique challenges for health systems.
NEW DELHI, Mar 19: The COVID-19 pandemic is throwing up unique challenges for health systems.
The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who…
The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who…
Information about COVID-19 is rapidly changing, and is committed to providing the most recent data in our coverage.
CALGARY - XORTX Therapeutics Inc. ('XORTX' or the 'Company') (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on…
• XRx-101 – a triple action approach to suppressing COVID-19 Injury • CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) -…
XRx-101 – a triple action approach to suppressing COVID-19 Injury CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) -- XORTX…
CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB…
XRx-101 – a triple action approach to suppressing COVID-19 Injury CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) -- XORTX…
• XRx-101 – a triple action approach to suppressing COVID-19 Injury • CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) -…